Pay to Marwadi
image 31 white

Tatva Chintan Pharma Chem Limited IPO: Study Before Subscribing

Share on facebook
Share on twitter
Share on linkedin

Incorporated in 1996, Tatva Chintan Pharma Chem Limited is a chemical manufacturing company that manufactures structure-directing agents (SDAs), phase transfer catalyst (PTCs), pharmaceutical and agrochemical intermediates, and other specialty chemicals. It is among the largest manufacturers of SDAs for zeolites in India.

About Tatva Chintan Pharma Chem Limited

The company serves customers across industries, i.e. automotive, petroleum, agrochemicals, dyes and pigments, paints and coatings, pharmaceutical, personal care, etc. Its products are sold in India and export to 25+ countries all over the world, such as the USA, Germany, South Africa, China, and the UK. In FY 2020, total export contributed to 76% of total revenue from operations.

Merck, Bayer AG, Ipox Chemicals, Laurus labs, Navin Fluorine International Limited, Atul Limited, Otsuka Chemicals, SRF Limited, Hawks Chemical Company, Firmenich Aromatics Prod Pvt Ltd, and Divi’s laboratories are a few of customers of the company. It currently operates through two manufacturing facilities situated at Ankleshwar and Dahej in Gujarat, both strategically located very close to the Hazira port. In addition, they have a dedicated R&D facility at Vadodara, Gujarat, with state-of-the-art research and development infrastructure.

This is the fourth specialty company to launch its IPO in 2021, after Clean Science & Technology, Laxmi Organic Industries, and Anupam Rasayan India.

Tatva Chintan Pharma Chem Limited IPO Issue Details

OPENS ON: July 16, 2021
CLOSES ON: July 20, 2021
Price band: Rs. 1073 – Rs.1083 per share
Lot size: 13 shares
One lot costing: Rs. 14,079
Face Value: Rs. 10 per share
Listing on: NSE, BSE
Issue size: Rs. 500 crores (Fresh issue: Rs. 225 cr + Offer For Sale: Rs. 275 cr)
Shareholding: Promoter holding will stand at 79.17% post-issue from 100% pre-issue.

Will list on the exchange on July 29, 2021.

Objects of the issue:

  • Funding capital expenditures requirements for expansion of Dahej manufacturing facility
  • Funding capital expenditures requirements to upgrade R&D facilities in Vadodara.
  • Meet general corporate purposes.

Interesting facts about Tatva Chintan Pharma Chem Limited IPO:

  • Leading manufacturer of structure-directing agents and phase transfer catalysts.
  • Global market presence with a customer base across industries.
  • Strategically located manufacturing facility in Gujarat with proximity to Hazira Port.
  •  Strong financial performance track record.

Get the complete coverage of the Tatva Chintan Pharma Chem Ltd IPO in the MSFL Research Report Here. To apply for Tatva Chintan Pharma Chem Ltd IPO, you can do it from our Marwadi Shares & Finance Ltd website.

Related Posts